Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
International Journal of Cardiology Congenital Heart Disease
ISSN 2666-6685 · Elsevier · Netherlands
International Journal of Cardiology Congenital Heart Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.5 (journal website); fully open access; APC about USD 2,260; median 71 days to acceptance (98 articles, last 24 months); 85 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
International Journal of Cardiology Congenital Heart Disease is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Congenital Heart Disease Studies, Pulmonary Hypertension Research and Treatments and Cardiovascular Issues in Pregnancy, together about 45.3% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Advancing Knowledge & Care for the Most Common and Global Inborn DefectAffiliated to: the International Society for Adult Congenital Heart Disease, the Japanese Society for Adult Congenital Heart Disease and the Italian Society of Pediatric and Congenital CardiologyIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (by invitation only), Guidelines, Editorials, CHD Perspectives, CHD Pulse (by invitation only), Abstracts from Meetings and Correspondence reporting on congenital heart disease and related outcomes, technology and innovation, congenital cardiac surgery and catheter interventions, multi-modality imaging, electrophysiology, devices and sudden cardiac death, genetics, pulmonary arterial hypertension, pregnancy and heart disease, life-style issues, patient education and patient empowerment and health policy.Articles must be authentic, educational, clinically relevant, and original in their content and scientific approach. IJC Congenital Heart Disease requires the highest standards of scientific integrity in order to promote reliable, reproducible and verifiable research findings. All authors are advised to consult the Principles of Ethical Publishing in the Journal before submitting a manuscript. Submission ofa manuscript to this journal gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Michael GatzoulisPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United Kingdom 26, Italy 14, United States 12, Japan 3, Canada 3 (83 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Congenital Heart Disease StudiesMedicine31.3%
- Pulmonary Hypertension Research and TreatmentsMedicine7.2%
- Cardiovascular Issues in PregnancyMedicine6.9%
- Cardiac Valve Diseases and TreatmentsMedicine6.7%
- Cardiac Structural Anomalies and RepairMedicine5.9%
- Cardiac Arrhythmias and TreatmentsMedicine5.2%
- Cardiovascular Function and Risk FactorsMedicine4.2%
- Coronary Artery AnomaliesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.5Publisher website ·
- CiteScore 2026-06
- 2LetPub ·
- CiteScore (publisher)
- 2Publisher website ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 45OpenAlex ·
- 2-year mean citedness
- 1.43OpenAlex ·
- Self-citation rate
- 13.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 78LetPub ·
Articles by year OpenAlex count · 614 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 62 | 6 |
| 2025 | 85 | 85 | 118 |
| 2024 | 71 | 71 | 188 |
| 2023 | 48 | 48 | 153 |
| 2022 | 103 | 103 | 335 |
| 2021 | 222 | 222 | 620 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
71 daysMedian, submission to acceptance · P25–P75 42 days – 101 days
- Acceptance to online
- median 2 days (98 articles)
- Submission to online
- median 72 days
- Sample
- 98 articles with submission and acceptance dates (168 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 32 daysPublisher website ·
- Submission to acceptance
- 61 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,260 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,120 / EUR 1,980 / GBP 1,700 / JPY 262,940 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,430 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted9
- abstracts from meetingsIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- chd perspectivesIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- chd pulseIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- correspondenceIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- debatesIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- editorialsIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- guidelinesIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- original articlesIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
- reviewsIJC Congenital Heart Disease (CHD) is an online-only, open-access journal dedicated to publishing Original Articles, Reviews (largely by invitation), Debates (b…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2666-6685
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal of Cardiology Congenital Heart Disease
What CAS zone is International Journal of Cardiology Congenital Heart Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Cardiology Congenital Heart Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Cardiology Congenital Heart Disease?
The journal's website gives an impact factor of 1.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 2, h-index 15.
How long does peer review take at International Journal of Cardiology Congenital Heart Disease?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 71 days (interquartile range 42–101 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Cardiology Congenital Heart Disease?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Cardiology Congenital Heart Disease based?
Of the 83 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United Kingdom (26), Italy (14) and United States (12). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Cardiology Congenital Heart Disease?
According to LetPub and DOAJ records, International Journal of Cardiology Congenital Heart Disease is indexed in ESCI, Scopus and DOAJ.
Is International Journal of Cardiology Congenital Heart Disease open access, and what is the APC?
International Journal of Cardiology Congenital Heart Disease is a fully open-access journal. APC about USD 2,260.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .